Last Week in GER Research: Ascletis Pharma, China Tower, Pinduoduo, Beigene and CNFinance
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight our sensitivity analysis for Ascletis...
1k Views
Bank of Jiujiang IPO Review - Not as Good as Jiangxi Bank
Bank of Jiujiang Co Ltd (6190 HK) is looking to raise up to US$500m in its upcoming IPO. Proceeds raised will be used to strengthen capital base to...
355 Views
Jiangxi Bank – Flattered Credit Costs Before IPO with Highest Asset Expansion of Peers
China’s Jiangxi Bank Co Ltd (1916 HK; "JBCL") is the newest bank to list from the Mainland on the Hong Kong market. It is clear from its most...
343 Views
Smartkarma: ECM Coverage Weekly Update (16 June 2018)
The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. Its a short week in...
314 Views
Jiangxi Bank IPO Review - Non-Standard Credit Assets Account for 39% of FY17 Interest Income
Jiangxi Bank Co Ltd (1916 HK) is looking to raise up to almost US$1bn in its upcoming IPO. Proceeds will mainly be used to strengthen the bank's...
276 Views